13 Nishisono F M. Understanding of and therapy for eating disorders—psychiatric views. Seishin Shinkeigaku Zasshi, 2009, 111: 854-858
[2]
14 Lee S, Ng K L, Kwok K, et al. The changing profile of eating disorders at a tertiary psychiatric clinic in Hong Kong (1987-2007). Int J Eat Disord, 2010, 43: 307-314
[3]
15 Javaras K N, Pope H G, Lalonde J K, et al. Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry, 2008, 69: 266-273
[4]
16 Blinder B J. Eating disorders in psychiatric illness. West J Med, 1991, 155: 519-520
[5]
17 Hinney A, Nguyen T T, Scherag A, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE, 2007, 2: e1361
[6]
18 Scuteri A, Sanna S, Chen W M, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesityrelated traits. PLoS Genet, 2007, 3: e115
[7]
19 Pinheiro A P, Bulik C M, Thornton L M, et al. Association study of 182 candidate genes in anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet, 2010, 153: 1070-1080
[8]
20 Scherag S, Hebebrand J, Hinney A. Eating disorders: the current status of molecular genetic research. Eur Child Adolesc Psychiatry, 2010, 19: 211-226
[9]
21 Stark C, Breitkreutz B J, Chatr-Aryamontri A, et al. The BioGRID Interaction Database: 2011 update. Nucleic Acids Res, 2011, 39 (Database issue): D698-D704
[10]
22 Prasad T S, Goel R, Kandasamy K, et al. Human Protein Reference Database—2009 update. Nucleic Acids Res, 2009, 37 (Database issue): D767-D772
[11]
23 Willis R C, Hogue C W. Searching, viewing, and visualizing data in the Biomolecular Interaction Network Database (BIND). Curr Protoc Bioinformatics, 2006, 12: 8.9.1-8.9.30
[12]
24 Maglott D, Ostell J, Pruitt K D, et al. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res, 2011, 39 (Suppl 1): D52-D57
[13]
25 Hermjakob H, Fleischmann W, Apweiler R. Swissknife—‘lazy parsing'' of SWISS-PROT entries. Bioinformatics, 1999, 15: 771-772
[14]
26 Croft D, O''Kelly G, Wu G, et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res, 2011, 39 (Suppl 1): D691-D697
[15]
27 Feramisco J D, Sadreyev R I, Murray M L, et al. Phenotypic and genotypic analyses of genetic skin disease through the Online Mendelian Inheritance in Man (OMIM) database. J Invest Dermatol, 2009, 129: 2628-2636
[16]
28 Kanehisa M, Goto S, Hattori M, et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res, 2006, 34 (Suppl 1): D354-D357
[17]
29 Nishimura D. BioCarta. Biotech Software & Internet Report, 2001, 2: 117-120
[18]
30 Kong L, Cheng L, Fan L Y, et al. IQdb: an intelligence quotient score-associated gene resource for human intelligence. Database, 2013, 2013: bat063
[19]
31 Zhao M, Qu H. PathLocdb: a comprehensive database for the subcellular localization of metabolic pathways and its application to multiple localization analysis. BMC genomics, 2010, 11 (Suppl 4): S13
[20]
32 Zhao M, Chen X, Gao G, et al. RLEdb: a database of rate-limiting enzymes and their regulation in human, rat, mouse, yeast and E. coli. Cell Res, 2009, 19: 793-795
[21]
33 Zhao M, Chen Y, Qu D, et al. TSdb: a database of transporter substrates linking metabolic pathways and transporter systems on a genome scale via their shared substrates. Sci China Life Sci, 2011, 54: 60-64
[22]
34 Xie C, Mao X, Huang J, et al. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res, 2011, 39 (Suppl 2): W316-W322
[23]
35 Huang da W, Sherman B T, Lempicki R A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res, 2009, 37: 1-13
[24]
36 Bialecka M, Drozdzik M, Klodowska-Duda G, et al. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson''s disease. Acta Neurol Scand, 2004, 110: 260-266
[25]
37 Urwin R E, Nunn K P. Epistatic interaction between the monoamine oxidase A and serotonin transporter genes in anorexia nervosa. Eur J Hum Genet, 2005, 13: 370-375
[26]
38 Glaab E, Baudot A, Krasnogor N, et al. Extending pathways and processes using molecular interaction networks to analyse cancer genome data. BMC Bioinformatics, 2010, 11: 597
[27]
39 Lorincz A M, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer, 2006, 13: 279-292
[28]
40 Hoda M R, Hamza A, Fischer K, et al. Obesity as a risk factor for prostate cancer: role for adipocytokines and involvement of tyrosine kinase pathway. Aktuelle Urol, 2010, 41: 178-183
[29]
41 Nakajima T E, Yamada Y, Hamano T, et al. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci, 2010, 101: 1286-1291
[30]
42 Smith M R, Lee H, Fallon M A, et al. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer. Urology, 2008, 71: 318-322
[31]
43 Kaur T, Zhang Z F. Obesity, breast cancer and the role of adipocytokines. Asian Pac J Cancer Prev, 2005, 6: 547-552
[32]
44 Housa D, Housova J, Vernerova Z, et al. Adipocytokines and cancer. Physiol Res, 2006, 55: 233-244
[33]
45 Housova J, Anderlova K, Krizova J, et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab, 2005, 90: 1366-1370
[34]
46 Tagami T, Satoh N, Usui T, et al. Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab, 2004, 89: 1833-1837
[35]
47 Morton G J, Cummings D E, Baskin D G, et al. Central nervous system control of food intake and body weight. Nature, 2006, 443: 289-295
[36]
48 Belgardt B F, Okamura T, Bruning J C. Hormone and glucose signalling in POMC and AgRP neurons. J Physiol, 2009, 587: 5305-5314
[37]
49 de Piano A, Tock L, Carnier J, et al. The role of nutritional profile in the orexigenic neuropeptide secretion in nonalcoholic fatty liver disease obese adolescents. Eur J Gastroenterol Hepatol, 2010, 22: 557-563
[38]
50 Speliotes E K, Willer C J, Berndt S I, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet, 2010, 42: 937-948
[39]
51 Barth S, Klein P, Horbach T, et al. Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters. Obes Facts, 2010, 3: 245-251
[40]
52 Maury E, Brichard S M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol, 2010, 314: 1-16
[41]
53 Galic S, Oakhill J S, Steinberg G R. Adipose tissue as an endocrine organ. Mol Cell Endocrinol, 2010, 316: 129-139
[42]
54 Benton C R, Holloway G P, Han X X, et al. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1α) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats. Diabetologia, 2010, 53: 2008-2019
[43]
55 Phillips C M, Goumidi L, Bertrais S, et al. ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat. J Lipid Res, 2010, 51: 3500-3507
[44]
56 Steinberg G R, McAinch A J, Chen M B, et al. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab, 2006, 91: 3592-3597
[45]
57 Karp P D, Ouzounis C A, Moore-Kochlacs C, et al. Expansion of the BioCyc collection of pathway/genome databases to 160 genomes. Nucleic Acids Res, 2005, 33: 6083-6089
[46]
58 Cellini E, Castellini G, Ricca V, et al. Glucocorticoid receptor gene polymorphisms in Italian patients with eating disorders and obesity. Psychiatr Genet, 2010, 20: 282-288
[47]
59 Dostalova I, Kunesova M, Duskova J, et al. Adipose tissue resistin levels in patients with anorexia nervosa. Nutrition, 2006, 22: 977-983
[48]
60 Krizova J, Dolinkova M, Lacinova Z, et al. Adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype. Physiol Res, 2008, 57: 539-546
[49]
61 Zhao M, Qu H. Human liver rate-limiting enzymes influence metabolic flux via branch points and inhibitors. BMC genomics, 2009, 10 (Suppl 3): S31
[50]
62 Zhao M, Qu H. High similarity of phylogenetic profiles of rate-limiting enzymes with inhibitory relation in human, mouse, rat, budding yeast and E. coli. BMC genomics, 2011, 12 (Suppl 3): S10
[51]
63 Edwards Y J, Beecham G W, Scott W K, et al. Identifying consensus disease pathways in Parkinson''s disease using an integrative systems biology approach. PLoS ONE, 2011, 6: e16917
[52]
64 Zhao M, Sun J and Zhao Z. Synergetic regulatory networks mediated by oncogene-driven microRNAs and transcription factors in serous ovarian cancer. Molecular bioSystems, 2013, 9, 3187-3198.
[53]
65 Andrews R C, Walker B R. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci, 1999, 96: 513-523
[54]
66 Rosmond R, Chagnon Y C, Holm G, et al. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res, 2000, 8: 211-218
[55]
67 Meller N, Altman A, Isakov N. New perspectives on PKCtheta, a member of the novel subfamily of protein kinase C. Stem Cells, 1998, 16: 178-192
[56]
68 Kim J K, Fillmore J J, Sunshine M J, et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest, 2004, 114: 823-827
[57]
1 Bulik C M, Hebebrand J, Keski-Rahkonen A, et al. Genetic epidemiology, endophenotypes, and eating disorder classification. Int J Eat Disord, 2007, 40 (Suppl): S52-S60
[58]
2 Swanson S A, Crow S J , Le Grange D, et al. Prevalence and correlates of eating disorders in adolescents: results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry, 2011, 68: 714-723
[59]
3 Wang K, Zhang H, Bloss C S, et al. A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. Mol Psychiatry, 2011, 16: 949-959
[60]
4 Hudson J I, Hiripi E, Pope H G Jr, et al. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry, 2007, 61: 348-358
[61]
5 Becker K G, Barnes K C, Bright T J, et al. The genetic association database. Nat Genet, 2004, 36: 431-432
[62]
6 Chanoine P, Spector N D. Hyperlipidemia, eating disorders, and smoking cessation. Curr Opin Pediatr, 2008, 20: 734-739
[63]
7 Anzengruber D, Klump K L, Thornton L, et al. Smoking in eating disorders. Eat Behav, 2006, 7: 291-299
[64]
8 Morgan J F, Lacey J H. Smoking, eating disorders, and weight control. Postgrad Med J, 1999, 75: 127
[65]
9 Dean E, Lomi C, Bruno S, et al. Addressing the common pathway underlying hypertension and diabetes in people who are obese by maximizing health: the ultimate knowledge translation gap. Int J Hypertens, 2011, 2011: 835805
[66]
11 Waaddegaard M, Davidsen M, Kj？ller M. Obesity and prevalence of risk behaviour for eating disorders among young Danish women. Scand J Public Health, 2009, 37: 736-743
[67]
12 Day J, Ternouth A, Collier D A. Eating disorders and obesity: two sides of the same coin? Epidemiol Psichiatr Soc, 2009, 18: 96-100
[68]
10 Schwartz M B, Henderson K E. Does obesity prevention cause eating disorders? J Am Acad Child Adolesc Psychiatry, 2009, 48: 784-786
